Clinical Trial Update: Atherosclerosis Risk in Communities (ARIC)

View source ↗

Summary

ARIC is a long-term NHLBI-sponsored observational study focused on atherosclerosis and cardiovascular disease. This update notes that the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Coronary Heart Disease
• Diabetes Mellitus
• Heart Failure

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Coronary Disease | Status: COMPLETED